RevenueNet IncomeP/EP/SEBITDividendStocksMarket capitalizationDebtLiabilitiesEquityAAQSEmployeesROEROAROCE
Isofol Medical AB (publ) Stock

Isofol Medical AB (publ) Equity 2024

Isofol Medical AB (publ) Equity

121.43 M SEK

Ticker

ISOFOL.ST

ISIN

SE0009581051

WKN

A2DPV6

In 2024, Isofol Medical AB (publ)'s equity was 121.43 M SEK, a -23.39% increase from the 158.5 M SEK equity in the previous year.

Isofol Medical AB (publ) Aktienanalyse

What does Isofol Medical AB (publ) do?

Isofol Medical AB (publ) is a Swedish company that was founded in 2006 and is listed on the Nasdaq Stockholm exchange. The company focuses on the development of medical solutions for a wide range of diseases, with a particular emphasis on cancer treatment. Isofol's main product is Modufolin, a proprietary technology that is an advancement of the well-known drug Folic Acid, commonly used in cancer therapy. Modufolin has a longer duration in the body, making it more effective in inhibiting tumor cell growth. Isofol also has a diagnostic division that specializes in developing tests for detecting Vitamin B12 levels in the body, which are crucial for identifying diseases such as dementia and anemia. Isofol Medical AB (publ) ist eines der beliebtesten Unternehmen auf Eulerpool.com.

Equity Details

Analyzing Isofol Medical AB (publ)'s Equity

Isofol Medical AB (publ)'s equity represents the ownership interest in the company, calculated as the difference between total assets and total liabilities. It reflects the residual claim by shareholders on the company’s assets after all debts have been paid. Understanding Isofol Medical AB (publ)'s equity is essential for assessing its financial health, stability, and value to shareholders.

Year-to-Year Comparison

Evaluating Isofol Medical AB (publ)'s equity over successive years offers insights into the company's growth, profitability, and capital structure. Increasing equity indicates an enhancement in net assets and financial health, while decreasing equity could point to rising debts or operational challenges.

Impact on Investments

Isofol Medical AB (publ)'s equity is a crucial element for investors, influencing the company's leverage, risk profile, and return on equity (ROE). Higher equity levels generally suggest lower risk and enhanced financial stability, making the company a potentially attractive investment opportunity.

Interpreting Equity Fluctuations

Fluctuations in Isofol Medical AB (publ)’s equity can arise from various factors, including changes in net income, dividend payments, and issuance or buyback of shares. Investors analyze these shifts to gauge the company's financial performance, operational efficiency, and strategic financial management.

Frequently Asked Questions about Isofol Medical AB (publ) stock

What is the equity of Isofol Medical AB (publ) this year?

Isofol Medical AB (publ) has equity of 121.43 M SEK this year.

What was the equity of Isofol Medical AB (publ) compared to the previous year?

The equity of Isofol Medical AB (publ) has increased/decreased by -23.39% decreased compared to the previous year.

What impact does a high equity have on investors of Isofol Medical AB (publ)?

A high equity is advantageous for investors of Isofol Medical AB (publ) as it is an indicator of the company's financial stability and its ability to manage risks and challenges.

What impact does low equity have on investors of Isofol Medical AB (publ)?

A low equity can be a risk for investors of Isofol Medical AB (publ), as it can put the company in a weaker financial position and impair its ability to manage risks and challenges.

How does an increase in equity of Isofol Medical AB (publ) affect the company?

An increase in equity of Isofol Medical AB (publ) can strengthen the company's financial position and improve its ability to make investments in the future.

How does a reduction in the equity of Isofol Medical AB (publ) affect the company?

A reduction in equity of Isofol Medical AB (publ) can affect the financial situation of the company and lead to a higher dependence on debt capital.

What are some factors that influence the equity of Isofol Medical AB (publ)?

Some factors that can affect the equity of Isofol Medical AB (publ) include profits, dividend payments, capital increases, and acquisitions.

Why is the equity of Isofol Medical AB (publ) so important for investors?

The equity of Isofol Medical AB (publ) is important for investors as it is an indicator of the financial strength of the company and can be an indication of how well the company is able to fulfill its financial obligations.

What strategic measures can Isofol Medical AB (publ) take to change the equity?

To change equity, Isofol Medical AB (publ) can take various measures such as increasing profits, conducting capital increases, reducing expenses, and acquiring companies. It is important for the company to perform a thorough review of its financial situation to determine the best strategic actions to modify its equity.

How much dividend does Isofol Medical AB (publ) pay?

Over the past 12 months, Isofol Medical AB (publ) paid a dividend of 0.76 SEK . This corresponds to a dividend yield of about 23.06 %. For the coming 12 months, Isofol Medical AB (publ) is expected to pay a dividend of 0.76 SEK.

What is the dividend yield of Isofol Medical AB (publ)?

The current dividend yield of Isofol Medical AB (publ) is 23.06 %.

When does Isofol Medical AB (publ) pay dividends?

Isofol Medical AB (publ) pays a quarterly dividend. This is distributed in the months of .

How secure is the dividend of Isofol Medical AB (publ)?

Isofol Medical AB (publ) paid dividends every year for the past 0 years.

What is the dividend of Isofol Medical AB (publ)?

For the upcoming 12 months, dividends amounting to 0.76 SEK are expected. This corresponds to a dividend yield of 23.06 %.

In which sector is Isofol Medical AB (publ) located?

Isofol Medical AB (publ) is assigned to the 'Health' sector.

Wann musste ich die Aktien von Isofol Medical AB (publ) kaufen, um die vorherige Dividende zu erhalten?

To receive the latest dividend of Isofol Medical AB (publ) from 2/20/2023 amounting to 0.755 SEK, you needed to have the stock in your portfolio before the ex-date on 2/14/2023.

When did Isofol Medical AB (publ) pay the last dividend?

The last dividend was paid out on 2/20/2023.

What was the dividend of Isofol Medical AB (publ) in the year 2023?

In the year 2023, Isofol Medical AB (publ) distributed 0 SEK as dividends.

In which currency does Isofol Medical AB (publ) pay out the dividend?

The dividends of Isofol Medical AB (publ) are distributed in SEK.

Stock savings plans offer an attractive way for investors to build wealth over the long term. One of the main advantages is the so-called cost-average effect: by regularly investing a fixed amount in stocks or stock funds, you automatically buy more shares when prices are low, and fewer when they are high. This can lead to a more favorable average price per share over time. In addition, stock savings plans allow small investors access to expensive stocks, as they can participate with small amounts. Regular investment also promotes a disciplined investment strategy and helps to avoid emotional decisions, such as impulsive buying or selling. Furthermore, investors benefit from the potential appreciation of the stocks as well as from dividend distributions, which can be reinvested, enhancing the compounding effect and thus the growth of the invested capital.

Andere Kennzahlen von Isofol Medical AB (publ)

Our stock analysis for Isofol Medical AB (publ) Revenue stock includes important financial indicators such as revenue, profit, P/E ratio, P/S ratio, EBIT, as well as information on dividends. We also assess aspects such as stocks, market capitalization, debt, equity, and liabilities of Isofol Medical AB (publ) Revenue. If you are looking for more detailed information on these topics, we offer comprehensive analyses on our subpages.